![Jennifer Mendoza](https://cdn.statcdn.com/static/../CMS/contactperson/ERI2166_1721301667.jpg)
COVID-19: impact on biotech R&D in Spain 2020
More than 55 percent of the biotechnology companies surveyed by the Spanish Bioindustry Association (ASEBIO) stated that COVID-19 had adversely affected research and development due to delayed projects and objectives. In contrast, 16.42 percent answered that COVID-19 had a positive impact because it opened new projects and speeded-up plans.